Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 6Neoplasms 3Lung Neoplasms 3Uterine Cervical Neoplasms 2Smoking Cessation 2Prostatic Neoplasms 2Communication 2Colorectal Neoplasms 2Uveal Melanoma 1Triple Negative Breast Neoplasms 1Tobacco Use Cessation 1Thyroid Neoplasms 1Sexual Dysfunction, Physiological 1Rectal Neoplasms 1Patient Preference 1Patient Acceptance of Health Care 1Papillary Thyroid Microcarcinoma 1Melanoma 1Lung Cancer Screening 1Hematologic Neoplasms 1Health Behavior 1Glioblastoma 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Cancer Prevention 1Cancer Pain 1Brain Neoplasms 1Attitude to Health 1

Interventions

Paclitaxel 37Carboplatin 28pembrolizumab 19Surveys and Questionnaires 11temsirolimus 10Radiotherapy 10Cisplatin 10Doxorubicin 9Bevacizumab 9lenvatinib 8Docetaxel 8Nivolumab 7Metformin 7Gemcitabine 7Early Intervention, Educational 7Counseling 7Sirolimus 6Radiation 6Megestrol Acetate 6Indocyanine Green 6olaparib 5Topotecan 5Therapeutics 5Psychiatric Rehabilitation 5Methods 5Letrozole 5Ipilimumab 5Chemotherapy, Adjuvant 5ridaforolimus 4Trastuzumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Endometrial Neoplasms × Focus Groups × Clear all
NCT04474184 2023-11-18

Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates

Mayo Clinic

Phase 1 Completed
33 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡